new_0222_0269|STOK|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|sga_expense|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|short_interest|forward_pe_ratio|forward_pe_ratio_1y|forward_ps_ratio|forward_ps_ratio_1y|quarterly_eps_estimates|quarterly_sales_estimates|quarterly_eps_surprise|quarterly_sales_surprise|quarterly_eps_actual|quarterly_sales_actual|sales_est_0y|sales_est_1y|price_target|consensus_recommendation|price_target_num_est|eps_est_0y|eps_est_1y|r_and_d_expense|reconciled_depreciation|interest_expense_non_operating|land_and_improvements|buildings_and_improvements|other_properties|machinery_furniture_equipment|price_next_month|price_second_month
new_0222_0269|STOK|1|Stoke Therapeutics Inc Total Current Assets (Quarterly) (USD)|Stoke Therapeutics Inc Cash and Short Term Investments (Quarterly) (USD)|Stoke Therapeutics Inc Inventories (Quarterly) (USD)|Stoke Therapeutics Inc Net PP&E (Quarterly) (USD)|Stoke Therapeutics Inc Goodwill and Intangibles (Quarterly) (USD)|Stoke Therapeutics Inc Total Liabilities (Quarterly) (USD)|Stoke Therapeutics Inc Total Current Liabilities (Quarterly) (USD)|Stoke Therapeutics Inc Total Long Term Liabilities (Quarterly) (USD)|Stoke Therapeutics Inc Total Deposits (Quarterly) (USD)|Stoke Therapeutics Inc Book Value (Quarterly) (USD)|Stoke Therapeutics Inc Retained Earnings (Quarterly) (USD)|Stoke Therapeutics Inc Treasury Stock (Quarterly) (USD)|Stoke Therapeutics Inc EV to Revenues|Stoke Therapeutics Inc EV to Earnings|Stoke Therapeutics Inc EV to Free Cash Flow|Stoke Therapeutics Inc EV to Assets (Quarterly)|Stoke Therapeutics Inc PS Ratio|Stoke Therapeutics Inc PE Ratio|Stoke Therapeutics Inc Price to Book Value|Stoke Therapeutics Inc PEG Ratio|Stoke Therapeutics Inc Debt to Equity Ratio|Stoke Therapeutics Inc Dividend Yield|Stoke Therapeutics Inc Shareholder Yield (TTM)|Stoke Therapeutics Inc Percent of Shares Outstanding Short|Stoke Therapeutics Inc Total Receivables (Quarterly) (USD)|Stoke Therapeutics Inc Total Payables (Quarterly) (USD)|Stoke Therapeutics Inc Total Capital Stock (Quarterly) (USD)|Stoke Therapeutics Inc Return on Invested Capital|Stoke Therapeutics Inc Quality Ratio Score|Stoke Therapeutics Inc Momentum Score|Stoke Therapeutics Inc Beta (1Y)|Stoke Therapeutics Inc Sustainable Growth Rate (TTM)|Stoke Therapeutics Inc Institutional Investor Ownership Percentage|Stoke Therapeutics Inc Average Diluted Shares Outstanding (Quarterly)|Stoke Therapeutics Inc Total Employees (Annual)|Stoke Therapeutics Inc EPS Diluted (Quarterly) (USD)|Stoke Therapeutics Inc SG&A Expense (Quarterly) (USD)|Stoke Therapeutics Inc Shares Outstanding|Stoke Therapeutics Inc Repurchase of Capital Stock (Quarterly) (USD)|Stoke Therapeutics Inc Ordinary Shares Number (Quarterly)|Stoke Therapeutics Inc Payout Ratio|Stoke Therapeutics Inc Quick Ratio (Quarterly)|Stoke Therapeutics Inc Normalized Diluted EPS (Quarterly) (USD)|Stoke Therapeutics Inc Stock Buybacks (Quarterly) (USD)|Stoke Therapeutics Inc Effective Tax Rate (TTM)|Stoke Therapeutics Inc Return on Equity|Stoke Therapeutics Inc Net Income (TTM) (USD)|Stoke Therapeutics Inc Revenue (TTM) (USD)|Stoke Therapeutics Inc Dividend Per Share (Quarterly) (USD)|Stoke Therapeutics Inc Revenue (Quarterly) (USD)|Stoke Therapeutics Inc Gross Profit (Quarterly) (USD)|Stoke Therapeutics Inc Pre-Tax Income (Quarterly) (USD)|Stoke Therapeutics Inc Net Income (Quarterly) (USD)|Stoke Therapeutics Inc Net Interest Income (Quarterly) (USD)|Stoke Therapeutics Inc Price (USD)|Stoke Therapeutics Inc Total Return Price (USD)|Stoke Therapeutics Inc Enterprise Value (USD)|Stoke Therapeutics Inc 30-Day Average Daily Volume|Stoke Therapeutics Inc 1 Year Price Returns (Daily)|Stoke Therapeutics Inc Short Interest|Stoke Therapeutics Inc PE Ratio (Forward)|Stoke Therapeutics Inc PE Ratio (Forward 1y)|Stoke Therapeutics Inc PS Ratio (Forward)|Stoke Therapeutics Inc PS Ratio (Forward 1y)|Stoke Therapeutics Inc Quarterly EPS Estimates (USD)|Stoke Therapeutics Inc Quarterly Revenue Estimates (USD)|Stoke Therapeutics Inc Quarterly EPS Surprise|Stoke Therapeutics Inc Quarterly Revenue Surprise|Stoke Therapeutics Inc Quarterly Actual EPS (USD)|Stoke Therapeutics Inc Quarterly Actual Revenue (USD)|Stoke Therapeutics Inc Revenue Estimates for Current Fiscal Year (USD)|Stoke Therapeutics Inc Revenue Estimates for Next Fiscal Year (USD)|Stoke Therapeutics Inc Price Target (USD)|Stoke Therapeutics Inc Consensus Recommendation|Stoke Therapeutics Inc Price Target Num Estimates|Stoke Therapeutics Inc EPS Estimates for Current Fiscal Year (USD)|Stoke Therapeutics Inc EPS Estimates for Next Fiscal Year (USD)|Stoke Therapeutics Inc Research and Development Expense (Quarterly) (USD)|Stoke Therapeutics Inc Reconciled Depreciation (Quarterly) (USD)|Stoke Therapeutics Inc Non-Operating Interest Expense (Quarterly) (USD)|Stoke Therapeutics Inc Land and Improvements (Quarterly) (USD)|Stoke Therapeutics Inc Buildings and Improvements (Quarterly) (USD)|Stoke Therapeutics Inc Other Properties (Quarterly) (USD)|Stoke Therapeutics Inc Machine, Furniture & Equipment (Quarterly) (USD)||
new_0222_0269|STOK|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_per_share_metric|percent_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_USD_metric|figure_whole_USD_price|figure_money_USD_per_share_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric||
new_0222_0269|STOK|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily|monthly|quarterly|quarterly|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|monthly|monthly|monthly|monthly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly||
new_0222_0269|STOK|5|91.2727272727|91.2727272727||91.2727272727||91.2727272727|91.2727272727|91.2727272727||91.2727272727|91.2727272727||||7.01438848921||||6.96428571429|||1.44658753709||15.2903225806|91.2727272727|91.2727272727|91.2727272727|||32.2941176471|30.5263157895|||91.3571428571|286.5|91.3571428571|91.3571428571|33.7692307692||91.2727272727|||91.3571428571|91.4285714286|||91.2727272727|||||91.3571428571|91.3571428571|91.3571428571|6.96428571429|6.96428571429|6.96428571429|6.96268656716|1.44655581948|15.2903225806|||1.42307692308|1.44117647059|91.3333333333|91.3333333333|91.2857142857||91.2857142857|91.2857142857|27.3823529412|27.3823529412|18.64|8.24778761062|18.64|14.3384615385|15.7796610169|91.3571428571|91.3571428571||||91.2727272727|91.375||
new_0222_0269|STOK|6|11|11||11||11|11|11||11|11||||139||||140|||674||62|11|11|11|||17|19|||14|2|14|14|26||11|||14|7|||11|||||14|14|14|140|140|140|134|421|62|||26|34|12|12|7||7|7|34|34|50|113|50|65|59|14|14||||11|8||
new_0222_0269|STOK|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly||
new_0222_0269|STOK|201803||||||||||||||||||||||||||||||||||23.5118||-0.0813|0.66||||||-0.0813|-0.008||||||||-1.912|-1.912|||||||||||||||||||||||||1.252|0.032|||||||
new_0222_0269|STOK|201806||||||||||||||||||||||||||||||||||23.5118||-0.128|1.122||||||-0.128|0.008||||||||-3.01|-3.01|||||||||||||||||||||||||1.888|0.043|||||||
new_0222_0269|STOK|201809||||||||||||||||||||||||||||||||||23.5118||-0.1411|1.09||||||-0.1411|||||||||-3.317|-3.317|||||||||||||||||||||||||2.227|0.064|||||||
new_0222_0269|STOK|201812|106.143|105.399||1.192||2.471|2.467|0.004||105.066|-25.71||||||||||||||0.196|1.071|0.002|||||||23.5118||-0.1821|1.538|||30.2698|||-0.1821||||-12.521|||||-4.282|-4.282|0.27||||||||||||||||||||||||3.004|0.075||||1.485|0.07||
new_0222_0269|STOK|201903|101.276|98.651||1.396||3.353|3.343|0.01||99.579|-31.452||||||||||||||0.196|1.126|0.002|||||||30.2698||-0.1897|2.189|||30.2698|||-0.1897||||-16.351|||||-5.742|-5.742|0.58||||||||||||||||||||||||4.133|0.08||||1.396|||
new_0222_0269|STOK|201906|244.445|242.68||1.722||4.836|4.818|0.018||241.536|-39.271||||-44.3563||||8.344|||||0.3236|0.26|1.238|0.003|||||||5.0836|49|-1.54|2.422|32.6746||32.6746|||-1.54|-151.912|||-21.16|||||-7.819|-7.819|0.629|26.41|26.41|732.2334|388760.5667||101815|||||||||||||37.6667|1.5|3|-1.8135|-1.5741|6.023|0.105||||1.722||24.64|34.87
new_0222_0269|STOK|201909|236.68|233.049||1.942||5.144|4.916|0.228||233.683|-47.875||||-24.5889||||3.0871|||||1.9432|0.376|1.789|0.003|||||||32.7076||-0.26|3.324|32.7242||32.7242|||-0.26||||-26.447|||||-8.604|-8.604|1.236|22.79|22.79|502.9655|237923.9667||635898|||||||||||||35.75|1.5|4|-2.042|-1.4972|6.518|0.126||||1.942||29.02|24.96
new_0222_0269|STOK|201912|226.033|222.471||2.512||4.322|4.101|0.221||224.428|-58.035||||-25.7946||||3.8153|||||4.1425|0.281|0.751|0.003|||||||32.8618|56|-0.3092|3.979|32.8618||32.8618|||-0.3092||||-32.325|||||-10.16|-10.16|0.904|27.24|27.24|658.5108|150068.0667||1361291|||||-0.2963||69.6233||-0.09||||36.5|1.4286|6|-1.8871|-1.5067|7.089|0.139||||2.489|0.187|27.86|22.79
new_0222_0269|STOK|202003|215.774|211.288||4.862||6.499|5.455|1.044||214.342|-69.074||||-16.0203||||3.2852|||||8.3054|0.144|1.779|0.003|||||||32.8974||-0.34|4.52|32.9674||32.9674|||-0.34||||-37.622|||||-11.039|-11.039|0.674|22.38|22.38|514.809|269442.3333||2738054|||||-0.3731||8.8814||-0.34||||36.5|1.4286|6|-1.6003|-1.557|7.215|0.193||||4.862||23.55|26.45
new_0222_0269|STOK|202006|205.544|201.93||4.465||6.814|5.805|1.009||203.4|-82.033||||-15.0764||||3.8911|||||10.6866|0.009|0.904|0.003|||5|0.1685|||33.0547||-0.39|5.044|33.2125||33.2125|||-0.39||||-42.762|||||-12.959|-12.959|0.039|23.83|23.83|589.5239|141529.5333|-18.3065|3549304|||||-0.36||-8.3333||-0.39||||38.4|1.3333|5|-1.4903|-1.386|7.968|0.224||||4.465||26.14|28.97
new_0222_0269|STOK|202009|195.456|191.461||4.274||7.4|6.735|0.665||192.535|-95.717||||-22.0458||||5.6105|||||8.5215|0.002|1.095|0.003|||3|0.559|||33.2736||-0.41|5.602|33.3612||33.3612|||-0.41||||-47.842|||||-13.684|-13.684|-0.001|34.33|34.33|939.237|95203.5|55.8399|2842879|||||-0.4297||4.5779||-0.41||||38.2857|1.625|7|-1.571|-1.6771|8.109|0.234||||4.274||41.02|47.33
new_0222_0269|STOK|202012|293.93|287.308||3.79||11.847|11.425|0.422||286.078|-110.278||||-46.9595||||11.4868|||||9.7036|0.006|1.495|0.004|||9|0.921|||35.0896|79|-0.42|5.682|36.5771||36.5771|||-0.42||||-52.243|||||-14.561|-14.561|0.041|59.18|59.18|1959.4539|199480.4667|118.6794|3549298|||||-0.4239||0.92||-0.42||||56.5|1.5556|8|-1.5357|-1.8382|8.904|0.237||||5.051|0.216|65.2|59.26
new_0222_0269|STOK|202103|275.295|267.514||3.555||6.443|6.11|0.333||272.465|-127.071||||-24.7535||||4.7484|||||8.6137|0.006|1.496|0.004|||8|0.3032|||36.6432||-0.46|6.914|36.6978||36.6978|||-0.46||||-57.997|||||-16.793|-16.793|0.018|37.05|37.05|1071.108|198796.3333|69.607|3161037|||||-0.4377||-5.102||-0.46||||65.75|1.7778|8|-1.8248|-2.0978|9.913|0.236||||3.555||33.3|37.55
new_0222_0269|STOK|202106|260.233|251.226||4.142||9.381|8.197|1.184||255.069|-149.038||||-18.0777||||4.4472|||||6.3328|0.131|0.963|0.004|||5|0.4254|||36.7082||-0.6|7.934|36.7227||36.7227|||-0.6||||-67.005|||||-21.967|-21.967|0.034|33.01|33.01|944.2006|187330.1|41.2505|2325568|||||-0.4615||-30.0165||-0.6||||60.6667|1.7|9|-2.143|-2.2392|14.095|0.249||||4.142||28.99|26.18
new_0222_0269|STOK|202109|244.933|236.156||8.269||16.258|11.884|4.374||237.513|-171.635||||-11.9661||||3.746|||||5.379|0.045|0.655|0.004|||3|0.6728|||36.7593||-0.61|8.325|36.7804||36.7804|||-0.61||||-75.918|||||-22.597|-22.597|0.044|26|26|704.2506|117459.8|-24.037|1978406|||||-0.5467||-11.5786||-0.61||||60.4444|1.7|9|-2.1373|-2.2449|14.358|0.254||||8.269||23.8|24.9
new_0222_0269|STOK|202112|||||||||||||||-9.441||||3.4853|||||7.4467||||||2|-2.1369||||||||||||||||||||||||22.5|22.5|591.6415|247435.8333|-61.2627|2747828|||99.5985|651.3772|-0.6054||||||7|1.1614|61.4444|1.4|9|-2.2412|-2.501||||||||19.4|18.93
new_0222_0269|STOK|202203|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.195|15.015||||||||||||||||||||
new_0222_0269|STOK|202206|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.6475|||||||||||||||||||||
new_0222_0269|STOK|202209|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.685|||||||||||||||||||||
new_0222_0269|STOK|202212|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.69|||||||||||||||||||||